Basit öğe kaydını göster

dc.contributor.authorÖzşeker, Burak
dc.contributor.authorŞahin, Cem
dc.contributor.authorÖzşeker, Havva Solak
dc.contributor.authorEfe, S. Cumali
dc.contributor.authorKav, Taylan
dc.contributor.authorBayraktar, Yusuf
dc.date.accessioned2019-12-10T11:20:59Z
dc.date.available2019-12-10T11:20:59Z
dc.date.issued2016
dc.identifier.issn0278-0240
dc.identifier.urihttps://doi.org/10.1155/2016/5423043
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013222/
dc.identifier.urihttp://hdl.handle.net/11655/15413
dc.description.abstractOne of the regions of involvement of Behçet's disease (BD), a systematic inflammatory vasculitis with unknown etiology, is the gastrointestinal (GI) tract. Upper GI endoscopy, colonoscopy, and capsule endoscopy are frequently used methods to diagnose the intestinal involvement of BD. The aim of this study was to investigate the role of fecal calprotectin (FC) in the evaluation of intestinal involvement in BD. Material and Method. A total of 30 patients who were diagnosed with BD and had no GI symptoms and 25 individuals in the control group were included in this study. Results. Levels of FC were statistically significantly higher in patients with BD compared to the control group (p < 0.001). The correlation analysis performed including FC and markers of disease activity revealed a positive and statistically significant correlation between FC level and CRP and erythrocyte sedimentation rate (r: 0.255, p < 0.049, and r: 0.404, p < 0.001, resp.). FC levels in patients who were detected to have ulcers in the terminal ileum and colon in the colonoscopic examination were statistically significantly higher compared to the patients with BD without intestinal involvement (p = 0.01). Conclusion. The measurement of FC levels, in patients with BD who are asymptomatic for GI involvement, may be helpful to detect the possible underlying intestinal involvement.
dc.relation.isversionof10.1155/2016/5423043
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe Role Of Fecal Calprotectin In Evaluating Intestinal Involvement Of Behçet'S Disease
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalDisease Markers
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume2016
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster